Ken Griffin
MYOK

Ken Griffin’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Ken Griffin’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,700
Closed -$1.73M – 11859
2020
Q3 		$1.73M Sell
12,700
-50,400
-80% -$5.36M ﹤0.01% 5003
2020
Q2 		$6.1M Sell
63,100
-43,500
-41% -$3.63M ﹤0.01% 2813
2020
Q1 		$5M Buy
106,600
+24,200
+29% +$1.55M ﹤0.01% 2704
2019
Q4 		$6.01M Buy
+82,400
New +$5M ﹤0.01% 2855

Ken Griffin's MYOK Position: Q3 2020 in Review

Ken Griffin sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 146,932 shares — an estimated $15.6M sold.

Ken Griffin first reported a position in MYOK in Q4 2016 and held it in 13 quarters. The position peaked at $14.2M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Ken Griffin reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Ken Griffin sold 146,932 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $15.6M.
  • Ken Griffin first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 13 quarters.
  • Ken Griffin's MyoKardia, Inc. Common Stock position peaked at $14.2M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.